Advertisement
U.S. markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed Price. Currency in USD
580.05-4.10 (-0.70%)
At close: 04:00PM EDT
590.96 +10.91 (+1.88%)
After hours: 08:00PM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
42,857,000
42,857,000
44,915,000
39,211,000
32,218,000
Cost of Revenue
25,757,000
25,757,000
25,944,000
19,573,000
16,214,000
Gross Profit
17,100,000
17,100,000
18,971,000
19,638,000
16,004,000
Operating Expense
9,782,000
9,782,000
10,464,000
9,413,000
8,111,000
Operating Income
7,318,000
7,318,000
8,507,000
10,225,000
7,893,000
Net Non Operating Interest Income Expense
-496,000
-496,000
-454,000
-493,000
-488,000
Other Income Expense
-524,000
-524,000
-218,000
-891,000
-175,000
Pretax Income
6,298,000
6,298,000
7,835,000
8,841,000
7,230,000
Tax Provision
284,000
284,000
703,000
1,109,000
850,000
Earnings from Equity Interest Net of Tax
-59,000
-59,000
-172,000
-4,000
-3,000
Net Income Common Stockholders
5,995,000
5,995,000
6,950,000
7,725,000
6,375,000
Diluted NI Available to Com Stockholders
5,995,000
5,995,000
6,950,000
7,725,000
6,375,000
Basic EPS
15.34
15.52
17.75
19.62
16.09
Diluted EPS
15.26
15.45
17.63
19.46
15.96
Basic Average Shares
387,500
386,000
392,000
394,000
396,000
Diluted Average Shares
388,750
388,000
394,000
397,000
399,000
Total Operating Income as Reported
6,859,000
6,859,000
8,393,000
10,028,000
7,794,000
Total Expenses
35,539,000
35,539,000
36,408,000
28,986,000
24,325,000
Net Income from Continuing & Discontinued Operation
5,995,000
5,995,000
6,950,000
7,725,000
6,375,000
Normalized Income
6,433,302
6,433,302
7,053,771
7,897,375
6,462,318
Interest Income
879,000
879,000
272,000
43,000
65,000
Interest Expense
1,375,000
1,375,000
726,000
536,000
553,000
Net Interest Income
-496,000
-496,000
-454,000
-493,000
-488,000
EBIT
7,673,000
7,673,000
8,561,000
9,377,000
7,783,000
EBITDA
11,079,000
11,079,000
11,942,000
11,969,000
10,108,000
Reconciled Cost of Revenue
25,757,000
25,757,000
25,944,000
19,573,000
16,214,000
Reconciled Depreciation
3,406,000
3,406,000
3,381,000
2,592,000
2,325,000
Net Income from Continuing Operation Net Minority Interest
5,995,000
5,995,000
6,950,000
7,725,000
6,375,000
Total Unusual Items Excluding Goodwill
-459,000
-459,000
-114,000
-197,000
-99,000
Total Unusual Items
-459,000
-459,000
-114,000
-197,000
-99,000
Normalized EBITDA
11,538,000
11,538,000
12,056,000
12,166,000
10,207,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-20,698
-20,698
-10,229
-24,625
-11,682